urlscan.io logo urlscan.io
SecurityTrails logo

biopharmaapac.com Open in urlscan Pro
191.96.144.104  Public Scan

Go To Rescan Add Verdict Report
Submitted URL: https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwia...
Effective URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-chin...
Submission: On May 17 via manual from IN — Scanned from AU
 Behaviour Indicators
Similar DOM Content API
Verdicts

Summary

This website contacted 7 IPs in 1 countries across 8 domains to perform 42 HTTP transactions. The main IP is 191.96.144.104, located in Phoenix, United States and belongs to AS-HOSTINGER, CY. The main domain is biopharmaapac.com.
TLS certificate: Issued by R3 on May 6th 2024. Valid for: 3 months.
This is the only time biopharmaapac.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 54.156.232.179 14618 (AMAZON-AES)
31 191.96.144.104 47583 (AS-HOSTINGER)
1 172.217.167.110 15169 (GOOGLE)
5 142.251.221.68 15169 (GOOGLE)
2 192.229.237.25 15133 (EDGECAST)
1 142.250.204.8 15169 (GOOGLE)
1 142.251.221.67 15169 (GOOGLE)
1 142.250.204.14 15169 (GOOGLE)
42 7
1    54.156.232.179 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-54-156-232-179.compute-1.amazonaws.com
t.dripemail2.com
31    191.96.144.104 (Phoenix, United States)

ASN47583 (AS-HOSTINGER, CY)
biopharmaapac.com
1    172.217.167.110 (United States)

ASN15169 (GOOGLE, US)
PTR: syd09s17-in-f14.1e100.net
www.youtube.com
5    142.251.221.68 (Farmingdale, United States)

ASN15169 (GOOGLE, US)
PTR: syd09s31-in-f4.1e100.net
www.google.com
2    192.229.237.25 (United States)

ASN15133 (EDGECAST, US)
platform.twitter.com
1    142.250.204.8 (United States)

ASN15169 (GOOGLE, US)
PTR: syd09s25-in-f8.1e100.net
www.googletagmanager.com
1    142.251.221.67 (Farmingdale, United States)

ASN15169 (GOOGLE, US)
PTR: syd09s31-in-f3.1e100.net
www.gstatic.com
1    142.250.204.14 (United States)

ASN15169 (GOOGLE, US)
PTR: syd09s25-in-f14.1e100.net
www.google-analytics.com
Apex Domain
Subdomains		 Transfer
31 biopharmaapac.com
biopharmaapac.com
853 KB
5 google.com
www.google.com — Cisco Umbrella Rank: 2
935 B
2 twitter.com
platform.twitter.com — Cisco Umbrella Rank: 1357
28 KB
1 google-analytics.com
www.google-analytics.com — Cisco Umbrella Rank: 32
255 B
1 gstatic.com
www.gstatic.com
200 KB
1 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 39
100 KB
1 youtube.com
www.youtube.com — Cisco Umbrella Rank: 64
1 dripemail2.com
t.dripemail2.com — Cisco Umbrella Rank: 191453
152 B
42 8
Domain Requested by
31 biopharmaapac.com biopharmaapac.com
5 www.google.com biopharmaapac.com
www.gstatic.com
2 platform.twitter.com biopharmaapac.com
platform.twitter.com
1 www.google-analytics.com www.googletagmanager.com
1 www.gstatic.com www.google.com
1 www.googletagmanager.com biopharmaapac.com
1 www.youtube.com biopharmaapac.com
1 t.dripemail2.com 1 redirects
42 8
Subject Issuer Validity Valid
biopharmaapac.com
R3		 2024-05-06 -
2024-08-04		 3 months crt.sh
*.google.com
GTS CA 1C3		 2024-05-06 -
2024-07-29		 3 months crt.sh
*.twimg.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1		 2023-07-28 -
2024-07-26		 a year crt.sh
*.google-analytics.com
GTS CA 1C3		 2024-05-06 -
2024-07-29		 3 months crt.sh
*.gstatic.com
GTS CA 1C3		 2024-05-06 -
2024-07-29		 3 months crt.sh

This page contains 7 frames:

Primary Page: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Frame ID: 381A50E48A4F7945A326265C367CEDEE
Requests: 36 HTTP requests in this frame

Frame: https://www.youtube.com/embed/lOcQEjAN7YU
Frame ID: ADA87BADB16100972FD19949DB7853B2
Requests: 1 HTTP requests in this frame

Frame: https://platform.twitter.com/widgets/widget_iframe.2f70fb173b9000da126c79afe2098f02.html?origin=https%3A%2F%2Fbiopharmaapac.com
Frame ID: CBB136A59482A1A5CAA72A15AAD927A3
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=en&v=vjbW55W42X033PfTdVf6Ft4q&size=normal&cb=7quxc58334wr
Frame ID: 4F072498C9D0D5F14F53B8AEC31ECC8F
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=en&v=vjbW55W42X033PfTdVf6Ft4q&size=normal&cb=ft453vmkjtxd
Frame ID: 0016738B6AE0E7D66FC7CAEB8C910104
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=en&v=vjbW55W42X033PfTdVf6Ft4q&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Frame ID: 0FCECD6AB14B9B29AAC40E26418739E9
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=en&v=vjbW55W42X033PfTdVf6Ft4q&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Frame ID: 5A6996C8B6211C6842B843BFB393E0C0
Requests: 1 HTTP requests in this frame

Screenshot
Live screenshot
Full Image

Page Title

Ractigen Therapeutics Receives IND Approval for Phase 1 ALS Clinical Trials in China

Page URL History Show full URLs

  1. https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6I... HTTP 307
    https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-cli... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]*?bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.css
  • bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.js
Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]+(?:([\d.]+)/)?(?:css/)?font-awesome(?:\.min)?\.css
  • <link[^>]* href=[^>]*?(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)
  • (?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)
Overall confidence: 100%
Detected patterns
Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtag/js
Overall confidence: 100%
Detected patterns
  • //platform\.twitter\.com/widgets\.js
Overall confidence: 100%
Detected patterns
  • jquery[.-]([\d.]*\d)[^/]*\.js
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?
Overall confidence: 100%
Detected patterns
  • /recaptcha/api\.js

Page Statistics

42
Requests

100 %
HTTPS

0 %
IPv6

8
Domains

8
Subdomains

7
IPs

1
Countries

1182 kB
Transfer

2079 kB
Size

6
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNzE1ODMxMTA2LCJuYmYiOjE3MTU4MzExMDYsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZGVsaXZlcnlfaWQiOiJqdGVqaTZueWoyaTFramZzdWxlcSIsInVybCI6Imh0dHBzOi8vYmlvcGhhcm1hYXBhYy5jb20vbmV3cy85Mi80NzcyL3JhY3RpZ2VuLXRoZXJhcGV1dGljcy1yZWNlaXZlcy1pbmQtYXBwcm92YWwtZm9yLXBoYXNlLTEtYWxzLWNsaW5pY2FsLXRyaWFscy1pbi1jaGluYS5odG1sP19fcz04dnNzZjgwZnI3YnJtaXNmanE2dSJ9.rcM04n7KMkh1sBERmIBwjfbrs5Gv9-l6dncoxI3tO7k HTTP 307
    https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

42 HTTP transactions

Resource
Path		 Size
x-fer		 Type
MIME-Type
Primary Request ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html
biopharmaapac.com/news/92/4772/
Redirect Chain
  • https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNzE1ODMxMTA2LCJuYmYiOjE3MTU4MzExMDYsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZ...
  • https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
54 KB
15 KB 		Document
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn / PHP/7.0.33
Resource Hash
10c781eca80b83bbdb80331ebfc7895b02ff94c36127043704180928b99610dc
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

Accept-Language
en-AU,en;q=0.9;q=0.9
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=86400
cache-control
no-cache
content-encoding
br
content-security-policy
upgrade-insecure-requests
content-type
text/html; charset=UTF-8
date
Fri, 17 May 2024 04:41:52 GMT
platform
hostinger
server
hcdn
x-hcdn-cache-status
DYNAMIC
x-hcdn-request-id
3ec613f99a69f060a495e2b52cb23f91-phx-edge1
x-hcdn-upstream-rt
0.501
x-powered-by
PHP/7.0.33

Redirect headers

content-length
0
date
Fri, 17 May 2024 04:41:50 GMT
location
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
bootstrap.min.css
biopharmaapac.com/bundles/taai/app/site/css/ 		157 KB
21 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/bootstrap.min.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
f77c0d1739b618edc4a01ca3f6b2990b01a3009030af49ee8cf68e83052df194
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
4546
alt-svc
h3=":443"; ma=86400
content-length
21008
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"27288-658841b5-c558fc44806ec9b6;br"
x-hcdn-request-id
182a27e1c5fc53a0069cdfb1e5b5ffdb-phx-edge1
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 03:26:06 GMT
style.css
biopharmaapac.com/bundles/taai/app/site/css/ 		25 KB
6 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
ebdc5cfff9a360616e819fbd3cb79de32c18c8cc9bf5fde761c69b015ccab1d5
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
4546
alt-svc
h3=":443"; ma=86400
content-length
5242
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"6585-658841b5-d7545e5fc4eb3b36;br"
x-hcdn-request-id
e378a12136db8711f437c5ea8e71fa11-phx-edge1
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 03:26:06 GMT
font-awesome.min.css
biopharmaapac.com/bundles/taai/app/site/css/ 		20 KB
5 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
b769324e0921f9f649611113e65f528ebae5e140da8a7e63c5d6ea7bc7a33bc0
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
4546
alt-svc
h3=":443"; ma=86400
content-length
4377
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"511e-658841b5-37cf0363bbbb9110;br"
x-hcdn-request-id
6f783f89d5791f529e7731d8f4bbbe18-phx-edge1
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 03:26:06 GMT
normalize.min.css
biopharmaapac.com/bundles/taai/app/site/css/ 		2 KB
1 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/normalize.min.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
b76ffbb2665f82b493e054b50d3d1bb3f2a8b4233be1795ca9937956eef196bc
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
4546
alt-svc
h3=":443"; ma=86400
content-length
807
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"897-658841b5-7766ac21e4fe004a;br"
x-hcdn-request-id
28ed5564d77a2537dec83e8c5263f6e0-phx-edge1
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 03:26:06 GMT
custom-style.css
biopharmaapac.com/bundles/taai/app/site/css/ 		342 B
545 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/custom-style.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
e65117229d77c2ee86fca1f8753df08d81434bf55569e574a03bcabce77ce436
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
4546
alt-svc
h3=":443"; ma=86400
content-length
153
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"156-658841b5-b5014e6d05cc6cea;br"
x-hcdn-request-id
1b3321406b75bef620e6574067a0d276-phx-edge1
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 03:26:06 GMT
logo.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 		5 KB
6 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/logo.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
2d4d0901e283ba28355eeb5a5e942a66ea4659922635c24fbea0244ed1598dc5

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
5492
x-hcdn-request-id
7867bf04c599823c9692e2bcb5f71231-phx-edge1
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
5460
displayad_bioflo320_728x90px_en-58.gif
biopharmaapac.com/uploads/static/ 		67 KB
67 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/uploads/static/displayad_bioflo320_728x90px_en-58.gif
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
727716580a27f67355a553de8a1ee6c1b0b96e3d31e403c26a50a8d0e38fc57a
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-security-policy
upgrade-insecure-requests
age
5492
alt-svc
h3=":443"; ma=86400
content-length
68096
x-hcdn-cache-status
HIT
last-modified
Tue, 30 Apr 2024 07:41:18 GMT
server
hcdn
etag
"10a00-6630a09e-f7360aa79256a458;;;"
x-hcdn-request-id
b3df6075533f535a834e84f41b9f15f3-phx-edge1
content-type
image/gif
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 03:10:20 GMT
17247404334195733326-59.jpg
biopharmaapac.com/uploads/static/ 		15 KB
15 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/uploads/static/17247404334195733326-59.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
59f4391fc8620567a220740e662586c344e814b6a10a6e89b8f301774d6ee338

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
5492
x-hcdn-request-id
fb6ddeadb5ab4e172ff160d3c2b63844-phx-edge1
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
15390
oip-4772.jpg
biopharmaapac.com/uploads/articles/ 		15 KB
15 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/uploads/articles/oip-4772.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
5316fc0cf6b9008c16687e5bc0ec2a6c0dac6b36d62dec8f483343fcdc19fecd

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
1447
x-hcdn-request-id
32f7ac6c92c8c6df97c56c568056a30f-phx-edge1
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
15270
16421605736357482910-2105.png
biopharmaapac.com/uploads/static/ 		24 KB
24 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/uploads/static/16421605736357482910-2105.png
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
a94ec9082fdaf7a1274e6159c1aada2f7dad7adf2bbddd7033812740af162153

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2297
x-hcdn-request-id
eb57a1e8066531b804503a009e9c12a4-phx-edge1
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
24572
biotitan_banner_300x250_v_2-61.jpg
biopharmaapac.com/uploads/static/ 		11 KB
11 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/uploads/static/biotitan_banner_300x250_v_2-61.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
e2f10adc52e292836413e9bb155a379f5cf0ddbd78044a24d645a85b866bdc76

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
5490
x-hcdn-request-id
8a7c7b69c43ee3fd02966ed9c808ac84-phx-edge1
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
11504
biopharma_apac_website_banner_300_x_150_px_2_-64.png
biopharmaapac.com/uploads/static/ 		11 KB
11 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/uploads/static/biopharma_apac_website_banner_300_x_150_px_2_-64.png
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
2ea8b83f155a1c7a1b24ef264a3cdc3e0ccf8627d447962adc7168225855b10c

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
5489
x-hcdn-request-id
75a6d0fc32dcd2f66d19df7479108926-phx-edge1
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
11080
unnamed-62.gif
biopharmaapac.com/uploads/static/ 		36 KB
37 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/uploads/static/unnamed-62.gif
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
461c3cb2d353f837be8a4d1b9ed67e8accdce9af1d69fb0819e9c3d593fb06e0
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-security-policy
upgrade-insecure-requests
age
5489
alt-svc
h3=":443"; ma=86400
content-length
37253
x-hcdn-cache-status
HIT
last-modified
Thu, 15 Feb 2024 04:36:58 GMT
server
hcdn
etag
"9185-65cd94ea-254f3b0d30889995;;;"
x-hcdn-request-id
c724af115ecd3d55f17f8c95a196124b-phx-edge1
content-type
image/gif
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 03:10:23 GMT
lOcQEjAN7YU
www.youtube.com/embed/ Frame ADA8 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://www.youtube.com/embed/lOcQEjAN7YU
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.167.110 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
syd09s17-in-f14.1e100.net
Software
ESF /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
en-AU,en;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
br
content-type
text/html; charset=utf-8
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
cross-origin-resource-policy
cross-origin
date
Fri, 17 May 2024 04:41:52 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
origin-trial
AmhMBR6zCLzDDxpW+HfpP67BqwIknWnyMOXOQGfzYswFmJe+fgaI6XZgAzcxOrzNtP7hEDsOo1jdjFnVr2IdxQ4AAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTc1ODA2NzE5OSwiaXNTdWJkb21haW4iOnRydWV9
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=en-GB for more info."
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
pragma
no-cache
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
server
ESF
strict-transport-security
max-age=31536000
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
x-content-type-options
nosniff
x-xss-protection
0
14280220722498395040-63.jpg
biopharmaapac.com/uploads/static/ 		10 KB
11 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/uploads/static/14280220722498395040-63.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
564dc88c3ff6fcd82cfb3b2c3922829ee3540abd0566d80e12885ab8221baca8

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
5489
x-hcdn-request-id
ccf9f72ea8c2a0e244f4994c0ecfabdf-phx-edge1
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
10666
biopharma_apac_women_s_day_special-4471.jpg
biopharmaapac.com/uploads/articles/ 		170 KB
171 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/uploads/articles/biopharma_apac_women_s_day_special-4471.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
3248ad72ca2f25d3874e6a6dca3ecb489d6484a060287603c7d5e840d8e584c6

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
5488
x-hcdn-request-id
ef8704baaa2e29fb6b70df1ac0f255af-phx-edge1
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
174190
screenshot_2023_12_13_at_9_44_52_am_1_-4048.jpg
biopharmaapac.com/uploads/articles/ 		53 KB
54 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/uploads/articles/screenshot_2023_12_13_at_9_44_52_am_1_-4048.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
05a10bd44e20f26c785b3e4c31295801b9705145585465938c424d9af7bd66af

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
5488
x-hcdn-request-id
2532a08ba458a3bba54ae53c347db701-phx-edge1
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
54622
screenshot_2023_12_12_at_9_45_03_pm-4050.jpg
biopharmaapac.com/uploads/articles/ 		69 KB
70 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/uploads/articles/screenshot_2023_12_12_at_9_45_03_pm-4050.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
fb58550a82dc1147bd4dd6896f9b37a844ad655377c361757eb9f64c9e732235

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
5488
x-hcdn-request-id
80c3215c35861403afee61305eafbd3e-phx-edge1
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
70900
BPA-Newsletter.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 		16 KB
17 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/BPA-Newsletter.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
bef28bfc8c1557bc5c4e5ebab4bddbdb6bd154d3b3d3c46b6d5294fc96b1c7cf

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
5488
x-hcdn-request-id
3c779400f3f1e217f994a6e36b13dc0b-phx-edge1
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
16702
jquery-3.6.0.min.js
biopharmaapac.com/bundles/taai/app/site/js/ 		87 KB
30 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/jquery-3.6.0.min.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
ff1523fb7389539c84c65aba19260648793bb4f5e29329d2ee8804bc37a3fe6e
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
5492
alt-svc
h3=":443"; ma=86400
content-length
30021
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"15d9d-658841b5-76abcfcbc9734b31;br"
x-hcdn-request-id
d8cb17efe05b30b092035aab3fab103b-phx-edge1
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 03:10:20 GMT
popper.min.js
biopharmaapac.com/bundles/taai/app/site/js/ 		21 KB
7 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/popper.min.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
c776195ad46333c6c9a9fe3c74502ffea9a02faf122388ea3567922cc65a3060
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
5492
alt-svc
h3=":443"; ma=86400
content-length
7193
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"5309-658841b5-f0a1cf827833c88e;br"
x-hcdn-request-id
aec81792536a1882793ad8e3afda81a6-phx-edge1
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 03:10:20 GMT
bootstrap.min.js
biopharmaapac.com/bundles/taai/app/site/js/ 		62 KB
14 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/bootstrap.min.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
d8968086f7509df34c3278563dab87399da4f9dcdfb419818e3a309eedc70b88
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
5492
alt-svc
h3=":443"; ma=86400
content-length
14080
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"f708-658841b5-af11bc98bc815e7d;br"
x-hcdn-request-id
5bd75016588b2a412b39e661011004ee-phx-edge1
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 03:10:20 GMT
jquery.autoscroll.js
biopharmaapac.com/bundles/taai/app/site/js/ 		1 KB
970 B 		Script
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/jquery.autoscroll.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
c6be6411d784cb509362d794eb35273a24661f430ef0858982cac95fbb23e23d
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
5491
alt-svc
h3=":443"; ma=86400
content-length
565
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"59b-658841b5-93f15deffd8af24b;br"
x-hcdn-request-id
cb05af68ecfdb69936bc3f45d6269094-phx-edge1
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 03:10:21 GMT
script.js
biopharmaapac.com/bundles/taai/app/site/js/ 		8 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/script.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
6ac1a1a6d852a4b597abee6351f122b5363f1c3f153df5a2b60336bbbe61069d
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
5491
alt-svc
h3=":443"; ma=86400
content-length
1868
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"1ed5-658841b5-3be2fb36bd88fc41;br"
x-hcdn-request-id
f725196e1e21eeb8f604f030b279d2c1-phx-edge1
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 03:10:21 GMT
dips-site-common.js
biopharmaapac.com/bundles/taai/app/site/js/ 		5 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/dips-site-common.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
b316099d3d0439715256c4bf9b8b59f2323a0af63e65b33e668a1eb3972f2893
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
5491
alt-svc
h3=":443"; ma=86400
content-length
1639
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"13f4-658841b5-e31a95c6373499c0;br"
x-hcdn-request-id
9ff4abc0258719a70aef389ce2632bf4-phx-edge1
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 03:10:21 GMT
api.js
www.google.com/recaptcha/ 		1 KB
935 B 		Script
General
Check archive.org
Download Go to
Full URL
https://www.google.com/recaptcha/api.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.251.221.68 Farmingdale, United States, ASN15169 (GOOGLE, US),
Reverse DNS
syd09s31-in-f4.1e100.net
Software
GSE /
Resource Hash
174624dafeed053da385e028c7eb00ea9224ec49476a655abaa59e359a90e61f
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self'
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy
frame-ancestors 'self'
server
GSE
x-frame-options
SAMEORIGIN
content-type
text/javascript; charset=utf-8
cache-control
private, max-age=300
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
Fri, 17 May 2024 04:41:52 GMT
widgets.js
platform.twitter.com/ 		91 KB
28 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://platform.twitter.com/widgets.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
192.229.237.25 , United States, ASN15133 (EDGECAST, US),
Reverse DNS
Software
ECS (nwa/E78C) /
Resource Hash
173460e89e6a7244218badae2016f65c48a3eae9d400802273eeca18b07336f1

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Date
Fri, 17 May 2024 04:41:52 GMT
Content-Encoding
gzip
Age
145
x-amz-server-side-encryption
AES256
X-Cache
HIT
P3P
CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
Server-Timing
x-cache;desc= HIT,x-tw-cdn;desc=VZ
Content-Length
27597
Last-Modified
Mon, 11 Dec 2023 17:20:28 GMT
Server
ECS (nwa/E78C)
Etag
"824beb891744db98ccbd3a456e59e0f7+gzip"
Access-Control-Max-Age
3000
Access-Control-Allow-Methods
GET
Content-Type
application/javascript; charset=utf-8
Access-Control-Allow-Origin
*
x-tw-cdn
VZ
Cache-Control
public, max-age=1800
Vary
Accept-Encoding
articulate.min.js
biopharmaapac.com/bundles/taai/assets/global/plugins/text-to-speech/ 		8 KB
3 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/bundles/taai/assets/global/plugins/text-to-speech/articulate.min.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
a8a2031f7cb98a60f55670a991ce71d4b61aaf051a4bf4eaccb2620b218516ec
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
2297
alt-svc
h3=":443"; ma=86400
content-length
2410
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"1e7c-658841b5-526d778e2c41316a;br"
x-hcdn-request-id
541d0d12ae3de92ddbe1111eb794c098-phx-edge1
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 04:03:35 GMT
js
www.googletagmanager.com/gtag/ 		293 KB
100 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagmanager.com/gtag/js?id=G-2E2BXNMKP4
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.204.8 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
syd09s25-in-f8.1e100.net
Software
Google Tag Manager /
Resource Hash
b92eb22d2094b78b792afcdda312932343df8d6b6a5ff97e1ac3d5814b51e734
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
101574
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Fri, 17 May 2024 04:41:52 GMT
back-web.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 		132 KB
133 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/back-web.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
4a0238590c45138d7cb407a8270180fe598d45803283ebc70c21cf0661219e4c

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
5490
x-hcdn-request-id
c75158f57977f40c0e17b0f519e90ebf-phx-edge1
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
135668
newsletter-back-Banner.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 		22 KB
22 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/newsletter-back-Banner.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
1a55549577f4b44e7e810531834d5ec8648857b39832ab3567032fd1bfd4deaa

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
5488
x-hcdn-request-id
380827078dbba1f1fb8985ad8538c115-phx-edge1
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
22140
cd-icon-close.svg
biopharmaapac.com/bundles/taai/app/site/images/ 		696 B
748 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/cd-icon-close.svg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
ba3c42c97d16d249855dcfeed7daf64b7a6f56bb45948a5b6409c39bf037da92
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
5490
alt-svc
h3=":443"; ma=86400
content-length
351
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"2b8-658841b5-4ebfd1f75862087e;br"
x-hcdn-request-id
d2fcf9d7b4ad092da6f48e174e512a61-phx-edge1
content-type
image/svg+xml
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 03:10:22 GMT
fontawesome-webfont.woff
biopharmaapac.com/bundles/taai/app/site/fonts/ 		82 KB
82 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/bundles/taai/app/site/fonts/fontawesome-webfont.woff?v=4.1.0
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
66db52b456efe7e29cec11fa09421d03cb09e37ed1b567307ec0444fd605ce31
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css
Origin
https://biopharmaapac.com
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:52 GMT
content-security-policy
upgrade-insecure-requests
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
age
5491
etag
W/"14730-658841b5-d326144e0621bbb4;;;"
vary
Accept-Encoding
x-hcdn-request-id
f0d80d4e01b76dd2522814a3ba478a31-phx-edge1
content-type
application/font-woff
content-encoding
br
x-turbo-charged-by
LiteSpeed
platform
hostinger
alt-svc
h3=":443"; ma=86400
widget_iframe.2f70fb173b9000da126c79afe2098f02.html
platform.twitter.com/widgets/ Frame CBB1 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://platform.twitter.com/widgets/widget_iframe.2f70fb173b9000da126c79afe2098f02.html?origin=https%3A%2F%2Fbiopharmaapac.com
Requested by
Host: platform.twitter.com
URL: https://platform.twitter.com/widgets.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
192.229.237.25 , United States, ASN15133 (EDGECAST, US),
Reverse DNS
Software
ECS (nwa/E78F) /
Resource Hash

Request headers

Accept-Language
en-AU,en;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

Access-Control-Allow-Methods
GET
Access-Control-Allow-Origin
*
Age
4538280
Cache-Control
public, max-age=315360000
Content-Encoding
gzip
Content-Length
105429
Content-Type
text/html; charset=utf-8
Date
Fri, 17 May 2024 04:41:53 GMT
Etag
"81267302efdfb3e4524a22631a8fc99e+gzip"
Last-Modified
Mon, 11 Dec 2023 17:19:49 GMT
P3P
CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
Server
ECS (nwa/E78F)
Server-Timing
x-cache;desc= HIT,x-tw-cdn;desc=VZ
Vary
Accept-Encoding
X-Cache
HIT
x-amz-server-side-encryption
AES256
x-tw-cdn
VZ
recaptcha__en.js
www.gstatic.com/recaptcha/releases/vjbW55W42X033PfTdVf6Ft4q/ 		502 KB
200 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.gstatic.com/recaptcha/releases/vjbW55W42X033PfTdVf6Ft4q/recaptcha__en.js
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.251.221.67 Farmingdale, United States, ASN15169 (GOOGLE, US),
Reverse DNS
syd09s31-in-f3.1e100.net
Software
sffe /
Resource Hash
922b951591d52d44aa7015ebc95cab08192aa435b64f9016673ac5da1124a8b4
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/
Origin
https://biopharmaapac.com
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Thu, 16 May 2024 14:18:19 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
51814
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
204445
x-xss-protection
0
last-modified
Sun, 05 May 2024 20:00:16 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Fri, 16 May 2025 14:18:19 GMT
collect
www.google-analytics.com/g/ 		0
255 B 		Ping
General
Check archive.org
Download Go to
Full URL
https://www.google-analytics.com/g/collect?v=2&tid=G-2E2BXNMKP4&gtm=45je45f0v877295126za200&_p=1715920913107&gcd=13l3l3l3l1&npa=0&dma=0&cid=1681959747.1715920913&ul=en-au&sr=1600x1200&uaa=x86&uab=64&uafvl=Google%2520Chrome%3B125.0.6422.60%7CChromium%3B125.0.6422.60%7CNot.A%252FBrand%3B24.0.0.0&uamb=0&uam=&uap=Win32&uapv=10.0.0&uaw=0&are=1&frm=0&pscdl=noapi&_s=1&sid=1715920913&sct=1&seg=0&dl=https%3A%2F%2Fbiopharmaapac.com%2Fnews%2F92%2F4772%2Fractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html%3F__s%3D8vssf80fr7brmisfjq6u&dt=Ractigen%20Therapeutics%20Receives%20IND%20Approval%20for%20Phase%201%20ALS%20Clinical%20Trials%20in%20China&en=page_view&_fv=1&_nsi=1&_ss=1&_ee=1&tfd=2915
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-2E2BXNMKP4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.204.14 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
syd09s25-in-f14.1e100.net
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Fri, 17 May 2024 04:41:53 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://biopharmaapac.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
anchor
www.google.com/recaptcha/api2/ Frame 4F07 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=en&v=vjbW55W42X033PfTdVf6Ft4q&size=normal&cb=7quxc58334wr
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/vjbW55W42X033PfTdVf6Ft4q/recaptcha__en.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.251.221.68 Farmingdale, United States, ASN15169 (GOOGLE, US),
Reverse DNS
syd09s31-in-f4.1e100.net
Software
GSE /
Resource Hash
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-i2dIZC8wHnrMtIoBSBS7-Q' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
en-AU,en;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-i2dIZC8wHnrMtIoBSBS7-Q' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Fri, 17 May 2024 04:41:53 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
anchor
www.google.com/recaptcha/api2/ Frame 0016 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=en&v=vjbW55W42X033PfTdVf6Ft4q&size=normal&cb=ft453vmkjtxd
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/vjbW55W42X033PfTdVf6Ft4q/recaptcha__en.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.251.221.68 Farmingdale, United States, ASN15169 (GOOGLE, US),
Reverse DNS
syd09s31-in-f4.1e100.net
Software
GSE /
Resource Hash
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-C10Ko4DiXog6kxl9rFIHBg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
en-AU,en;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-C10Ko4DiXog6kxl9rFIHBg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Fri, 17 May 2024 04:41:53 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
favicon.ico
biopharmaapac.com/ 		1 KB
940 B 		Other
General
Check archive.org
Download Go to
Full URL
https://biopharmaapac.com/favicon.ico
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
191.96.144.104 Phoenix, United States, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
7428eb0737028b660f7ed162a0e6a8971d9fab47a1954ffd07ab90dce5582bad
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Accept-Language
en-AU,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 04:41:54 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
alt-svc
h3=":443"; ma=86400
content-length
544
x-hcdn-cache-status
MISS
last-modified
Sun, 31 Dec 2023 17:58:04 GMT
server
hcdn
etag
"47e-6591abac-69c23afe33127d87;br"
x-hcdn-request-id
483bb81c5a822756a1fc8904cb71761b-phx-edge2
content-type
image/x-icon
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
x-hcdn-upstream-rt
0.026
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 04:41:54 GMT
bframe
www.google.com/recaptcha/api2/ Frame 0FCE 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://www.google.com/recaptcha/api2/bframe?hl=en&v=vjbW55W42X033PfTdVf6Ft4q&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/vjbW55W42X033PfTdVf6Ft4q/recaptcha__en.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.251.221.68 Farmingdale, United States, ASN15169 (GOOGLE, US),
Reverse DNS
syd09s31-in-f4.1e100.net
Software
GSE /
Resource Hash
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-8L2JF-gSZoty5ZlvhYkFpw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
en-AU,en;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-8L2JF-gSZoty5ZlvhYkFpw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Fri, 17 May 2024 04:41:54 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
bframe
www.google.com/recaptcha/api2/ Frame 5A69 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://www.google.com/recaptcha/api2/bframe?hl=en&v=vjbW55W42X033PfTdVf6Ft4q&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/vjbW55W42X033PfTdVf6Ft4q/recaptcha__en.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.251.221.68 Farmingdale, United States, ASN15169 (GOOGLE, US),
Reverse DNS
syd09s31-in-f4.1e100.net
Software
GSE /
Resource Hash
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-TU88sWLHVd3dfNfukXlmew' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
en-AU,en;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-TU88sWLHVd3dfNfukXlmew' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Fri, 17 May 2024 04:41:54 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block

Verdicts & Comments Add Verdict or Comment

41 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| 6 object| 7 function| $ function| jQuery function| Popper object| bootstrap function| fncShow function| fncHide function| pagination function| validateEmail function| allNumeric function| saveEnquiry function| getParameterByName string| passwrodLength function| validatePassword function| validateRegistration function| validateLogin function| validateForgotPassword function| isEmailExist function| validateNewsletter object| __twttrll object| twttr object| __twttr function| gtag object| dataLayer object| ___grecaptcha_cfg object| grecaptcha string| __recaptcha_api boolean| __google_recaptcha_client object| google_tag_manager object| google_tag_data function| onYouTubeIframeAPIReady object| gaGlobal object| recaptcha object| closure_lm_359748

6 Cookies

Domain/Path Name / Value
biopharmaapac.com/ Name: PHPSESSID
Value: 89867t5n62n5radsvjnvg9u682
.youtube.com/ Name: YSC
Value: NHN-CVC7wIg
.youtube.com/ Name: VISITOR_INFO1_LIVE
Value: jl-YucdirxQ
.youtube.com/ Name: VISITOR_PRIVACY_METADATA
Value: CgJBVRIEGgAgJg%3D%3D
.biopharmaapac.com/ Name: _ga_2E2BXNMKP4
Value: GS1.1.1715920913.1.0.1715920913.0.0.0
.biopharmaapac.com/ Name: _ga
Value: GA1.1.1681959747.1715920913

1 Console Messages

Source Level URL
Text
recommendation verbose URL: https://biopharmaapac.com/news/92/4772/ractigen-therapeutics-receives-ind-approval-for-phase-1-als-clinical-trials-in-china.html?__s=8vssf80fr7brmisfjq6u
Message:
[DOM] Input elements should have autocomplete attributes (suggested: "current-password"): (More info: https://goo.gl/9p2vKq) %o

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Content-Security-Policy upgrade-insecure-requests

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

biopharmaapac.com
platform.twitter.com
t.dripemail2.com
www.google-analytics.com
www.google.com
www.googletagmanager.com
www.gstatic.com
www.youtube.com
142.250.204.14
142.250.204.8
142.251.221.67
142.251.221.68
172.217.167.110
191.96.144.104
192.229.237.25
54.156.232.179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